[18F]-FARAG

· CellSight Technologies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [18F]-FARAG, covering 2024-10-24 to 2024-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG [Phase 2]